Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NASH
Marketing
Meet Madrigal, which wants to be your liver's No. 1 fan
Madrigal is aiming to accomplish what has so far proven to be impossible: to bring a fatty liver drug across the FDA finish line and onto the market.
Ben Adams
Nov 15, 2023 9:40am
Madrigal, eyeing a NASH drug launch, nabs Dupixent vet as CCO
Nov 13, 2023 9:30am
Fierce 50: Breakthroughs honorees
Oct 2, 2023 4:00am
NASH market holds 'enormous untapped potential,' analysts say
Aug 10, 2023 10:00am
UPDATED: Intercept restructures as NASH hopes dashed by FDA
Jun 22, 2023 6:20pm
Intercept still has a long road ahead with Ocaliva in NASH
May 19, 2023 5:29pm
